TS
Thilo Schroeder (Director) filed 1 Form 4 report in the past 24 months (1 purchase, 0 sales), most often in Revolution Medicines, Inc. (RVMD). Across 1 priced purchase filing, the average 21-session return was -9.3% from execution and -7.1% from disclosure (delay-adjusted; derived). The largest single filing was $60.0M of RVMD (1,304,347 sh across 2 lots, as filed), executed Dec 5 2024. Data as of Nov 9 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
-9.3%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
-7.1%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells
Median delay
4d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$60.0M
shares × price, as filed
Last traded
Dec 5 2024
Filed Dec 9 2024
Median ADV $548.2M across their filed names
Open performance→Volume by month
Buys $60.0M
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 24 months
Most traded names
RVMDRecent filings
RVMDPURCHASE
Revolution Medicines, Inc.
View filing →
$60.0M1,304,347 sh across 2 lots
Exec Dec 5 2024
Filed Dec 9 2024 · 5:30 PM ET